Status:
COMPLETED
The Impact of Cardiac Rehabilitation Participation on Cardiac Syndrome X
Lead Sponsor:
National Heart and Lung Institute
Collaborating Sponsors:
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Microvascular Angina
Eligibility:
FEMALE
30-80 years
Phase:
PHASE2
Brief Summary
The study is designed to test the hypothesis that participation in a standard phase III group based cardiac rehabilitation programme will improve psychological morbidity, quality of life and cardiovas...
Detailed Description
Very few clinicians treating patients with Syndrome X could dispute that despite an excellent prognosis, the debilitating symptomology and ineffective treatment regimes typical in this condition give ...
Eligibility Criteria
Inclusion
- Women
- Aged 30 to 80 years
- Postmenopausal \> 1 year since last menstrual period
- Angiographically normal coronary arteries
- Positive treadmill exercise test for myocardial ischemia
- Reported angina pectoris \> 2 episodes per week
- Diagnosis \> 6 months
- Willing to give written informed consent
Exclusion
- History of psychiatric illness
- History of any other chronic illness
- Participation in another research study within the previous 60 days
- Suffer any physical condition for which exercise is a contra-indication.
- Unwilling to give written informed consent
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2005
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00123617
Start Date
January 1 2003
End Date
May 1 2005
Last Update
April 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart and Lung Institute, Imperial College London
London, United Kingdom, SW3 6LY